⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CTOR News
Citius Oncology, Inc. Common Stock
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
prnewswire.com
CTXR
CTOR
Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
prnewswire.com
CTXR
CTOR
Form 8-K
sec.gov
CTOR
Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization
prnewswire.com
CTOR
Form 8-K
sec.gov
CTOR
CTXR
Form 8-K
sec.gov
CTXR
CTOR
Citius Oncology Ships First International Order of LYMPHIR™ to Europe
prnewswire.com
CTXR
CTOR
Form 8-K
sec.gov
CTOR
Form 8-K
sec.gov
CTXR
CTOR
Form 8-K
sec.gov
CTOR
CTXR